We are aware of shortages of some strengths of Vyvanse (lisdexamfetamine dimesilate).
Currently there are shortages of Vyvanse 30 mg, 50 mg and 60 mg which are expected to continue until March and April 2024, depending on strength.
The most up-to-date information about these shortages, including the dates they are expected to end and the actions that we have taken can be found on the Medicine Shortage Reports database.
